Skip to main content
Erschienen in: Clinical Rheumatology 4/2014

01.04.2014 | Original Article

Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome

verfasst von: Yunyun Fei, Wen Zhang, Dongfang Lin, Chen Wu, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang

Erschienen in: Clinical Rheumatology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to investigate the correlation between clinical parameter, Th17, and degree of lymphocytes infiltrating in labial salivary gland in primary Sjögren’s syndrome (pSS). Minor labial gland biopsies from a cohort of 103 patients fulfilling the American-European consensus classification criteria for pSS were examined and grouped into G1 to G3 according to infiltration degree of lymphocytes in labial salivary glands and formation of germinal center. IL-17 level and Th17 proportion of peripheral blood samples in 54 patients with pSS were analyzed simultaneously. Among the 103 labial salivary glands samples, there were 10.5 % of G1, 68.4 % of G2, and 21.1 % of G3, respectively. Some clinical parameters were markedly associated with the degree of inflammatory cells infiltration in labial glands, including white blood cell counts, lymphocytes, liver enzymes, and pulmonary function diffusion rates. The average optical density of IL-17 correlated with the severity of lymphocytic infiltration in the labial glands, while the proportion of Th17 cells in the peripheral blood mononuclear cells showed no significant relationship to the degree of lymphocytic infiltration in the labial glands from the SS patients. IL-17A mRNA levels in peripheral blood mononuclear cells from pSS patients before immunosuppressant treatment were significantly higher than that in patients after immunosuppressant treatment. The degree of inflammatory cells infiltration in labial glands was related to some clinical manifestations in pSS. IL-17 may play a role in the pathogenesis of lymphocytic infiltration in the labial glands. Immunosuppressive treatment might affect Th17 cells.
Literatur
1.
Zurück zum Zitat Price EJ, Venables PJ (1995) The etiopathogenesis of Sjogren’s syndrome. Semin Arthritis Rheum 25:117–133PubMedCrossRef Price EJ, Venables PJ (1995) The etiopathogenesis of Sjogren’s syndrome. Semin Arthritis Rheum 25:117–133PubMedCrossRef
2.
Zurück zum Zitat Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T lymphocytes in Sjögren’s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32:252–264PubMedCrossRef Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T lymphocytes in Sjögren’s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32:252–264PubMedCrossRef
3.
Zurück zum Zitat Maehara T, Moriyama M, Hayashida JN et al (2012) Selective localization of T helper subsets in labial salivary glands from primary Sjögren’s syndrome patients. Clin Exp Immunol 169(2):89–99PubMedCentralPubMedCrossRef Maehara T, Moriyama M, Hayashida JN et al (2012) Selective localization of T helper subsets in labial salivary glands from primary Sjögren’s syndrome patients. Clin Exp Immunol 169(2):89–99PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Reksten TR, Jonsson MV, Szyszko EA et al (2009) Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford) 48(9):1102–1106CrossRef Reksten TR, Jonsson MV, Szyszko EA et al (2009) Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford) 48(9):1102–1106CrossRef
5.
Zurück zum Zitat Moriyama M, Hayashida JN, Toyoshima T et al (2012) Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren’s syndrome. Clin Exp Immunol 169(1):17–26PubMedCentralPubMedCrossRef Moriyama M, Hayashida JN, Toyoshima T et al (2012) Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren’s syndrome. Clin Exp Immunol 169(1):17–26PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Katsifis GE, Rekka S, Moutsopoulos NM et al (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175(3):1167–1177PubMedCentralPubMedCrossRef Katsifis GE, Rekka S, Moutsopoulos NM et al (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175(3):1167–1177PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Nguyen CQ, Hu MH, Li Y et al (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58(3):734–743PubMedCentralPubMedCrossRef Nguyen CQ, Hu MH, Li Y et al (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58(3):734–743PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Risselada AP, Looije MF, Kruize AA et al (2013) The role of ectopic germinal centers in the immunopathology of primary Sjögren’s syndrome: a systematic review. Semin Arthritis Rheum 42(4):368–376PubMedCrossRef Risselada AP, Looije MF, Kruize AA et al (2013) The role of ectopic germinal centers in the immunopathology of primary Sjögren’s syndrome: a systematic review. Semin Arthritis Rheum 42(4):368–376PubMedCrossRef
10.
Zurück zum Zitat Ohara T, Itoh Y, Itoh K (2000) Revaluation of laboratory parameters in relation to histological findings in primary and secondary Sjögren’s syndrome. Intern Med 39(6):457–463PubMedCrossRef Ohara T, Itoh Y, Itoh K (2000) Revaluation of laboratory parameters in relation to histological findings in primary and secondary Sjögren’s syndrome. Intern Med 39(6):457–463PubMedCrossRef
11.
Zurück zum Zitat Le Pottier L, Devauchelle V, Fautrel A et al (2009) Ectopic germinal centers are rare in Sjogren’s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 182(6):3540–3547PubMedCrossRef Le Pottier L, Devauchelle V, Fautrel A et al (2009) Ectopic germinal centers are rare in Sjogren’s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 182(6):3540–3547PubMedCrossRef
12.
Zurück zum Zitat Wong CK, Lit LC, Tam LS et al (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in autoimmunity. Clin Immunol 127:385–393PubMedCrossRef Wong CK, Lit LC, Tam LS et al (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in autoimmunity. Clin Immunol 127:385–393PubMedCrossRef
13.
Zurück zum Zitat Kim J, Kang S, Kim J et al (2013) Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 33(1):52–59PubMedCentralPubMedCrossRef Kim J, Kang S, Kim J et al (2013) Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 33(1):52–59PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Nguyen CQ, Hu MH, Li Y et al (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58:734–743PubMedCentralPubMedCrossRef Nguyen CQ, Hu MH, Li Y et al (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58:734–743PubMedCentralPubMedCrossRef
Metadaten
Titel
Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome
verfasst von
Yunyun Fei
Wen Zhang
Dongfang Lin
Chen Wu
Mengtao Li
Yan Zhao
Xiaofeng Zeng
Fengchun Zhang
Publikationsdatum
01.04.2014
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 4/2014
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2476-z

Weitere Artikel der Ausgabe 4/2014

Clinical Rheumatology 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.